Emraclidine

DB18706InvestigationalSmall molecule

Emraclidine: Overview.

Mechanism: Pharmacologically active on Muscarinic acetylcholine receptor M4
Curator reviewed
Formula / weight: C₂₀H₂₁F₃N₄O · 390.41 g/mol (avg)
Also known as: Ethanone, 1-(5,7-dihydro-2,4-dimethyl-6h-pyrrolo(3,4-b)pyridin-6-yl)-2-(1-(2-(trifluoromethyl)-4-pyridinyl)-3-azetidinyl)-
Code names: CVL-231

Resolves to

Compound

Structure

InChIKeyDTCZNKWBDTXEBS-UHFFFAOYSA-NSMILESCC1=CC(C)=C2CN(CC2=N1)C(=O)CC1CN(C1)C1=CC=NC(=C1)C(F)(F)F

Targets

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

13Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Emraclidine, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.